ZA200908355B - Gastroretentive system comprising an alginate body - Google Patents

Gastroretentive system comprising an alginate body

Info

Publication number: ZA200908355B
Authority: ZA; South Africa
Prior art keywords: gastroretentive system; alginate body; alginate; gastroretentive
Prior art date: 2007-06-04

Application number

ZA200908355A

Other languages

English (en)

Inventor

Bodo Asmussen

Christiane Schiller

Werner Weitschies

Original Assignee

Lohmann Therapie Syst Lts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-04

Filing date

2009-11-26

Publication date

2010-07-28

2009-11-26 Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts

2010-07-28 Publication of ZA200908355B publication Critical patent/ZA200908355B/xx

Links

FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 title 1
229940072056 alginate Drugs 0.000 title 1
235000010443 alginic acid Nutrition 0.000 title 1
229920000615 alginic acid Polymers 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA200908355A 2007-06-04 2009-11-26 Gastroretentive system comprising an alginate body ZA200908355B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102007026037A DE102007026037A1 (de)	2007-06-04	2007-06-04	Gastroretentives System mit Alginat-Körper

Publications (1)

Publication Number	Publication Date
ZA200908355B true ZA200908355B (en)	2010-07-28

Family

ID=39942026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200908355A ZA200908355B (en)	2007-06-04	2009-11-26	Gastroretentive system comprising an alginate body

Country Status (14)

Country	Link
US (1)	US20100129445A1 (fr)
EP (2)	EP2155172A2 (fr)
JP (1)	JP5425058B2 (fr)
KR (1)	KR101268215B1 (fr)
CN (1)	CN102215826A (fr)
AU (1)	AU2008258881B2 (fr)
CA (1)	CA2689049C (fr)
DE (1)	DE102007026037A1 (fr)
IL (1)	IL202518A0 (fr)
MX (1)	MX2009013086A (fr)
NZ (1)	NZ581740A (fr)
RU (1)	RU2468790C2 (fr)
WO (1)	WO2008148478A2 (fr)
ZA (1)	ZA200908355B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101118794B1 (ko) *	2009-11-10	2012-06-13	동아제약주식회사	비스포스포네이트를 함유하는 약학 조성물
US9532977B2 (en)	2010-12-16	2017-01-03	Celgene Corporation	Controlled release oral dosage forms of poorly soluble drugs and uses thereof
US20140018404A1 (en)	2010-12-16	2014-01-16	Celgene Corporation	Controlled release oral dosage forms of poorly soluble drugs and uses thereof
DE102011051653A1 (de) *	2011-07-07	2013-01-10	Lts Lohmann Therapie-Systeme Ag	Quellfähige Manteltablette
US10507127B2 (en)	2012-06-07	2019-12-17	Epitomee Medical Ltd.	Expandable device
EP2887925B1 (fr) *	2012-08-27	2017-02-22	Evonik Röhm GmbH	Composition pharmaceutique ou nutraceutique gastrorésistante présentant de la résistance vis-à-vis de l'influence de l'éthanol
WO2014032676A1 (fr) *	2012-09-03	2014-03-06	S-Biotek Holding Aps	Préparation orale solide destinée au traitement et/ou à la prévention du surpoids et/ou permettant de stabiliser le niveau de glycémie chez un patient
CN105899198A (zh)	2013-12-05	2016-08-24	图利普医疗有限公司	用于药物活性试剂的原位释放的滞留装置和系统
WO2017083348A1 (fr)	2015-11-11	2017-05-18	Celgene Corporation	Formes pharmaceutiques orales à libération contrôlée de médicaments faiblement solubles et leurs utilisations
CN108721246B (zh) *	2018-05-29	2021-06-25	王喆明	高分子材料构建的多单元超长效口服制剂及其制备方法
US11511093B2 (en)	2019-10-11	2022-11-29	Wonkwang University Center for Industry Academy Cooperation	Gastroretentive drug delivery device having expandable structure and manufacturing method therefor
KR102278915B1 (ko)	2019-10-24	2021-07-19	중앙대학교 산학협력단	다공성 하이드로겔을 유효성분으로 함유하는 위 체류 및 약물 방출 제어형 경구용 제제
US11529310B2 (en)	2020-12-08	2022-12-20	Ruminant Biotech Corp Limited	Devices and methods for delivery of substances to animals

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4207890A (en)	1977-01-04	1980-06-17	Mcneilab, Inc.	Drug-dispensing device and method
US4735804A (en) *	1985-05-10	1988-04-05	Merck & Co., Inc.	Drug delivery device which can be retained in the stomach for a controlled period of time
US4695463A (en) *	1985-05-24	1987-09-22	Warner-Lambert Company	Delivery system for active ingredients and preparation thereof
US4816262A (en)	1986-08-28	1989-03-28	Universite De Montreal	Controlled release tablet
IL87710A (en)	1987-09-18	1992-06-21	Ciba Geigy Ag	Covered floating retard form for controlled release in gastric juice
DE3803482A1 (de) *	1988-02-05	1989-08-17	Lohmann Therapie Syst Lts	Schwimmfaehiges orales therapeutisches system
US4983401A (en)	1989-05-22	1991-01-08	Kinaform Technology, Inc.	Sustained release pharmaceutical preparations having pH controlled membrane coatings
US5198227A (en)	1990-01-22	1993-03-30	Mcneil-Ppc, Inc.	Dual subcoated simulated capsule medicament
US5198229A (en) *	1991-06-05	1993-03-30	Alza Corporation	Self-retaining gastrointestinal delivery device
DK0542364T3 (da)	1991-11-13	1996-03-11	Glaxo Canada	Anordning til reguleret frigivelse
AU692483B2 (en) *	1993-10-29	1998-06-11	R.P. Scherer Corporation	Gelatin capsule fill able to foam
DE4419818C2 (de)	1994-06-07	1998-10-22	Lohmann Therapie Syst Lts	Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage und Verfahren zur Herstellung desselben
DE4431653C2 (de)	1994-09-06	2000-01-20	Lohmann Therapie Syst Lts	Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US20020002364A1 (en) *	1995-10-05	2002-01-03	Karsten Cremer	Osmotic device for the continuous release of active compounds into the fluids of the gastrointestinal tract
DE19537090A1 (de)	1995-10-05	1997-04-10	Lohmann Therapie Syst Lts	Osmotische Vorrichtung zur kontinuierlichen Freisetzung von Wirkstoffen in die Flüssigkeiten des Gastrointestinaltraktes
FR2784583B1 (fr) *	1998-10-16	2002-01-25	Synthelabo	Composition pharmaceutique a residence gastrique et a liberation controlee
US6797283B1 (en)	1998-12-23	2004-09-28	Alza Corporation	Gastric retention dosage form having multiple layers
US6497902B1 (en) *	1999-12-01	2002-12-24	The Regents Of The University Of Michigan	Ionically crosslinked hydrogels with adjustable gelation time
US6488962B1 (en)	2000-06-20	2002-12-03	Depomed, Inc.	Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
HUP0301465A3 (en)	2000-06-23	2006-07-28	Teva Pharma	Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
EP1240897B1 (fr) *	2001-03-14	2006-06-21	Pfizer Products Inc.	Comprimé pharmaceutique et son procédé de fabrication
EP1245227A1 (fr)	2001-03-31	2002-10-02	Jagotec Ag	Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
PL370793A1 (en)	2001-07-04	2005-05-30	Sun Pharmaceutical Industries Limited	Gastric retention controlled drug delivery system
US20040219186A1 (en)	2001-08-16	2004-11-04	Ayres James W.	Expandable gastric retention device
IN191024B (fr) *	2001-09-25	2003-09-13	J B Chemicals And Pharmaceutic
EP1524963A2 (fr)	2002-06-26	2005-04-27	Cadila Healthcare Ltd.	Nouvelles formes posologiques flottantes
US20060003003A1 (en)	2004-06-28	2006-01-05	Bakker Johan A	Oral sustained release formulation of tedisamil with gastric retention properties

2007
- 2007-06-04 DE DE102007026037A patent/DE102007026037A1/de not_active Withdrawn
2008
- 2008-05-27 WO PCT/EP2008/004188 patent/WO2008148478A2/fr not_active Ceased
- 2008-05-27 AU AU2008258881A patent/AU2008258881B2/en not_active Expired - Fee Related
- 2008-05-27 JP JP2010510670A patent/JP5425058B2/ja not_active Expired - Fee Related
- 2008-05-27 MX MX2009013086A patent/MX2009013086A/es not_active Application Discontinuation
- 2008-05-27 KR KR1020107000051A patent/KR101268215B1/ko not_active Expired - Fee Related
- 2008-05-27 EP EP08758774A patent/EP2155172A2/fr not_active Withdrawn
- 2008-05-27 CA CA2689049A patent/CA2689049C/fr not_active Expired - Fee Related
- 2008-05-27 CN CN2008800187472A patent/CN102215826A/zh active Pending
- 2008-05-27 US US12/451,926 patent/US20100129445A1/en not_active Abandoned
- 2008-05-27 EP EP12170347A patent/EP2497465A3/fr not_active Withdrawn
- 2008-05-27 RU RU2009147730/15A patent/RU2468790C2/ru not_active IP Right Cessation
- 2008-05-27 NZ NZ581740A patent/NZ581740A/en not_active IP Right Cessation
2009
- 2009-11-26 ZA ZA200908355A patent/ZA200908355B/xx unknown
- 2009-12-03 IL IL202518A patent/IL202518A0/en unknown

Also Published As

Publication number	Publication date
EP2497465A2 (fr)	2012-09-12
DE102007026037A1 (de)	2008-12-11
WO2008148478A8 (fr)	2009-02-05
NZ581740A (en)	2011-05-27
RU2009147730A (ru)	2011-06-27
WO2008148478A2 (fr)	2008-12-11
MX2009013086A (es)	2010-01-18
IL202518A0 (en)	2010-06-30
CN102215826A (zh)	2011-10-12
US20100129445A1 (en)	2010-05-27
WO2008148478A3 (fr)	2009-04-09
KR101268215B1 (ko)	2013-05-31
RU2468790C2 (ru)	2012-12-10
EP2155172A2 (fr)	2010-02-24
EP2497465A3 (fr)	2012-11-21
KR20100028621A (ko)	2010-03-12
CA2689049C (fr)	2014-07-08
JP2010529056A (ja)	2010-08-26
JP5425058B2 (ja)	2014-02-26
AU2008258881B2 (en)	2013-12-19
CA2689049A1 (fr)	2008-12-11
AU2008258881A1 (en)	2008-12-11

Publication	Publication Date	Title
IL202518A0 (en)	2010-06-30	Gastroretentive system comprising an alginate body
ZA201006144B (en)	2011-10-26	An intrauterine system
IL205588A0 (en)	2010-11-30	Vaginal delivery system
GB2455844B (en)	2012-07-11	An artificial ventilation system
EP2087437A4 (fr)	2010-10-27	Mise en commun temporelle basée sur des groupes
EP2114273A4 (fr)	2012-07-25	Système de fixation à blocage conique
EP1989992A4 (fr)	2012-02-15	Systeme d'endoscope
EP2183927A4 (fr)	2014-12-17	Systeme multimedia sans fil
PL2231311T3 (pl)	2019-02-28	Układ obróbki emisji
IL184773A0 (en)	2008-01-06	Bone plate shaping system
EP2182849A4 (fr)	2010-09-15	Système de lancette
GB0706762D0 (en)	2007-05-16	Interior attachment system
EP2009465A4 (fr)	2010-03-03	Système de mammographie
ZA201003697B (en)	2011-03-30	Antiemetic-oral contraceptive combination
IL218895A0 (en)	2012-06-28	An intrauterine system
EP2020200A4 (fr)	2014-11-12	Système d'endoscope
EP2088925A4 (fr)	2014-01-01	Système de positionnement dynamique d'un patient
EP2346443A4 (fr)	2012-03-07	Système d'assistance sexuelle
EP2240699A4 (fr)	2011-04-27	Monture de corps
GB2463995B (en)	2011-07-20	Body supports
EP2037968A4 (fr)	2009-12-23	Hydrogels biocompatibles
GB2444030B (en)	2009-06-24	Sex toy
HK1134252A (en)	2010-04-23	Gastroretentive system comprising an alginate body
GB2438373B (en)	2011-07-13	Uterine dilators set
GB0617821D0 (en)	2006-10-18	Escape system